共 242 条
[1]
Ajani JA(2002)Irinotecan plus cisplatin in patients with advanced untreated gastric or gastroesophageal junction carcinoma: results of a phase II study Cancer 94 641-undefined
[2]
Baker J(1999)Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer J Clin Oncol 17 319-undefined
[3]
Pisters PWT(2001)A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer Br J Cancer 84 470-undefined
[4]
Ho L(1994)Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research J Clin Oncol 12 2687-undefined
[5]
Mansfield PF(1997)Systemic treatment of gastric cancer Eur J Gastroentrol Hepatol 16 255-undefined
[6]
Feig BW(2003)Docetaxel in advanced gastric cancer: review of the main clinical trials Acta Oncol 42 693-undefined
[7]
Charnsangavej C(1997)Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer Ann Oncol 8 163-undefined
[8]
Boku N(1999)Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer J Clin Oncol 17 3270-undefined
[9]
Ohtsu A(1993)A late phase II study of irinotecan in patients with advanced gastric cancers Proc Am Soc Clin Oncol 12 198-undefined
[10]
Shimada Y(1995)Relationship between the pharmacokinetics of irinotecan and diarrhea during combination chemotherapy with cisplatin Jpn J Cancer Res 86 406-undefined